medigraphic.com
ISSN 1561-3100 (Print)

2020, Number 2

<< Back Next >>

Revista Cubana de Ortopedia y Traumatología 2020; 34 (2)

Septic arthritis of the knee as a presentation of multiple myeloma

Miró JY, Nápoles PM, Bacallao PY

Language: Spanish
References: 17
Page: 1-11
PDF size: 443.52 Kb.


ABSTRACT

Introduction: Multiple myeloma constitutes a malignant proliferation of plasma cells derived from a single clone. The tumor, its products, and the patient's response cause various organic functional disorders and symptoms such as bone pain or fractures, kidney failure, predisposition to infections, anemia, hypercalcemia, and sometimes coagulation disorders, neurological symptoms, and vascular manifestations of hyperviscosity.
Objective: To present a rare case, taking into account that acute infection as the initial presentation of myeloma is unusual.
Case report: We report a case of a 61-year-old patient, admitted to the orthopedic service on three different occasions and operated on for septic arthritis of the left knee, in every occasions. The local inflammatory elements at the joint level, recurrent fever, anemia and accelerated erythrocyte sedimentation were still present.
Conclusions: Specific hematological studies confirmed the diagnosis of multiple myeloma. Induction-to-remission treatment for this disease was started with melphalan and prednisone; improvement of the infection was achieved at the conclusion of the first cycle of this therapeutic intervention.


REFERENCES

  1. Nikhil C, Munshi Dan L, Longo Kenneth, Anderson C. En: Harrison. Principios de Medicina Interna. 18va ed. New York, USA: McGraw-Hill Companies; 2012: 936-44.

  2. Álvarez López A, Soto-Carrasco SR, García Lorenzo Y. Artritis séptica de la rodilla. AMC. jul-ago 2018;22(4).

  3. Bolaños Solís MF. Artritis séptica. Revista Médica Sinergia. ene 2017;2(1):22-5.

  4. Bladé Creixenti J, San Miguel Izquierdo JF. En: Farreras Valenti P, Rozman C, Cardellach López F. Tratado de Medicina Interna. 18va ed. Barcelona, España: Elsevier; 2016. p. 1671-81.

  5. Mathews CJ, Weston VC, Jones A, Field M, Coakley G. Bacterial septic arthritis in adults. Lancet. 2010;375 (9717):846-55.

  6. Kaandorp CJ, Van Schaardenburg D, Krijnen PJ, Dik FH, Van De Laar MA. Risk factors for septic arthritis in patients with joint disease. Arthritis Rheum. 1995;38(12):1819-25

  7. Rubio A, Rojo P. Osteomielitis y artritis séptica. Pediatr Integral. 2018 [citado 20 Ago-2019];22(7):316-22. Disponible en: Disponible en: https://www.pediatriaintegral.es/publicacion-2018-10/osteomielitis-y-artritis-septica/

  8. Illán Ramos M, Fernández García P, González-Romo F, Cabadas MI, Ramos Amador JT. Artritis séptica de rodilla por Kingella kingae. Presentación de dos casos clínicos. Pediátr Panamá. 2017;46 (3):40-5.

  9. Cuesta M, Bernad M, Espinosa A, Herranz P, Martin Mola E, Gijon Banos J. Pneumococcal septic arthritis as the ?rst manifestation of multiple myeloma. Clinical and Experimental Rheumatology. 1992;10:483-4.

  10. Kim J, Lee M, Kim TH. Nationwide epidemiologic study for pediatric osteomyelitis and septic arthritis in South Korea: A cross-sectional study of national health insurance review and assessment service. Medicine. 2019;98(17). doi: http://10.1097/MD.00000000000153

  11. Rajkumar SV, Kumar S. Multiple myeloma: Diagnosis and treatment. Mayo Clinic Proc. 2016;91(1):101-19. doi: http://10.1016/j.mayocp.2015.11.007

  12. Berenson J, Spektor T, Wang J. Advances in the Management of Multiple Myeloma. Journal of Community and Supportive Oncology. 2016;14(5):232-5.

  13. Florestano C, Fica A, Gaete N, Porte L, Braun S. Artritis séptica en pacientes adultos en un hospital general de Chile. Rev chil infectol. 2014;31(4). doi: http://dx.doi.org/10.4067/S0716-10182014000400009

  14. Alvarado-Ibarra M, Álvarez-Vera JL, Anaya-Cuéllar I, de la Peña-Celaya A, García-Fernández L, Hernández-Ruiz E, et al. Primer Consenso nacional de mieloma múltiple por hematólogos del ISSSTE. Rev Hematol Mex. 2015;16:306-32.

  15. Berenson J, Mieloma múltiple. Manual Merck, Hematología y oncología, trastorno de las células plasmáticas. Sept 2019 [citado 11 Jul 2020]. Disponible en: Disponible en: https://www.merckmanuals.com/es-us/professional/hematolog

  16. Villegas Gracia R, Franco Alzate C, Rendón Henao J, Torres Hernández JD, Jaramillo Arbelaez PE. Frequency of monoclonal B-cell lymphocytosis in relatives of patients with chronic lymphocytic leukemia. Rev Colombia Médica. 2016;47(2). doi: https://doi.org/10.25100/cm.v47i2.1879

  17. Villegas R, Jaramillo P, Cardona J. Prevalencia de linfocitosis monoclonal de células B y factores asociados: meta-análisis 2002-2012. Rev Cubana Hematol Inmunol Hemoter. 2015;31(2): 172-86.




2020     |     www.medigraphic.com